The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.
Statins for children with familial hypercholesterolemia
Open accessAbstract
BACKGROUND: Familial hypercholesterolemia is one of the most common inherited metabolic diseases and is an autosomal dominant disorder meaning heterozygotes, or carriers, are affected. Those who are homozygous have severe disease. The average worldwide prevalence of heterozygous familial hypercholesterolemia is at least 1 in 500, although recent genetic epidemiological data from Denmark and next generation sequencing data suggest the frequency may be closer to 1 in 250. Diagnosis of familial hypercholesterolemia in children is based on elevated total cholesterol and low-density lipoprotein cholesterol levels or DNA-based analysis, or both. Coronary atherosclerosis has been detected in men with heterozygous familial hypercholesterolemia as young as 17 years old and in women with heterozygous familial hypercholesterolemia at 25 years old. Since the clinical complications of atherosclerosis occur prematurely, especially in men, lifelong treatment, started in childhood, is needed to reduce the risk of cardiovascular disease. In children with the disease, diet was the cornerstone of treatment but the addition of lipid-lowering medications has resulted in a significant improvement in treatment. Anion exchange resins, such as cholestyramine and colestipol, were found to be effective, but they are poorly tolerated. Since the 1990s studies carried out on children aged 6 to 17 years with heterozygous familial hypercholesterolemia have demonstrated significant reductions in their serum total and low-density lipoprotein cholesterol levels. While statins seem to be safe and well-tolerated in children, their long-term safety in this age group is not firmly established. This is an update of a previously published version of this Cochane Review. OBJECTIVES: To assess the effectiveness and safety of statins in children with heterozygous familial hypercholesterolemia. SEARCH METHODS: Relevant studies were identified from the Group's Inborn Errors and Metabolism Trials Register and Medline.Date of most recent search: 20 February 2017. SELECTION CRITERIA: Randomized and controlled clinical studies including participants up to 18 years old, comparing a statin to placebo or to diet alone. DATA COLLECTION AND ANALYSIS: Two authors independently assessed studies for inclusion and extracted data. MAIN RESULTS: We found 26 potentially eligible studies, of which we included nine randomized placebo-controlled studies (1177 participants). In general, the intervention and follow-up time was short (median 24 weeks; range from six weeks to two years). Statins reduced the mean low-density lipoprotein cholesterol concentration at all time points (moderate quality evidence). Serum aspartate and alanine aminotransferase, as well as creatinine kinase concentrations, did not differ between treated and placebo groups at any time point (low quality evidence). The risks of myopathy (low quality evidence) and clinical adverse events (moderate quality evidence) were very low and also similar in both groups. In one study simvastatin was shown to improve flow-mediated dilatation of the brachial artery (low quality evidence), and in another study treatment with pravastatin for two years induced a significant regression in carotid intima media thickness (low quality evidence). AUTHORS' CONCLUSIONS: Statin treatment is an effective lipid-lowering therapy in children with familial hypercholesterolemia. No significant safety issues were identified. Statin treatment seems to be safe in the short term, but long-term safety remains unknown. Children treated with statins should be carefully monitored and followed up by their pediatricians and their care transferred to an adult lipidologist once they reach 18 years of age. Large long-term randomized controlled trials are needed to establish the long-term safety issues of statins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Regulation of the mevalonate pathway
Goldstein, J. L., & Brown, M. S. (1990) · Nature · doi:10.1038/343425a0 · Cited by 5,394
(2008) · Cited by 3,790
Assessing the quality of controlled clinical trials
Jüni, P., Altman, D. G., & Egger, M. (2001) · BMJ · doi:10.1136/bmj.323.7303.42 · Cited by 3,309
Nordestgaard, B. G., Chapman, M. J., Humphries, S. E., Ginsberg, H. N., Masana, L., Descamps, O. S., Wiklund, O., Hegele, R. A., Raal, F. J., Defesche, J. C., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht273 · Cited by 2,761
Self-citationStatins and risk of incident diabetes: A collaborative meta-analysis of randomised statin trials
Sattar, N., Preiss, D., Murray, H. M., Welsh, P., Buckley, B. M., de Craen, A. J., Seshasai, S. R. K., McMurray, J. J., Freeman, D. J., Jukema, J. W., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61965-6 · Cited by 2,436
Lipid screening and cardiovascular health in childhood
Daniels, S. R., Greer, F. R., & and the Committee on Nutrition (2008) · Pediatrics · doi:10.1542/peds.2008-1349 · Cited by 1,178
ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of Statins
Writing Committee Members:, Pasternak, R. C., Smith, S. C., Bairey-Merz, C. N., Grundy, S. M., Cleeman, J. I., & Lenfant, C. (2002) · Circulation · doi:10.1161/01.cir.0000032466.44170.44 · Cited by 1,088
Khera, A. V., Won, H.-H., Peloso, G. M., Lawson, K. S., Bartz, T. M., Deng, X., van Leeuwen, E. M., Natarajan, P., Emdin, C. A., Bick, A. G., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.03.520 · Cited by 942
Drug Treatment of Lipid Disorders
Knopp, R. H. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908123410707 · Cited by 845
Statin Safety: A Systematic Review
Law, M., & Rudnicka, A. R. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.12.010 · Cited by 808
Swerdlow, D. I., Preiss, D., Kuchenbaecker, K. B., Holmes, M. V., Engmann, J. E. L., Shah, T., Sofat, R., Stender, S., Johnson, P. C. D., Scott, R. A., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61183-1 · Cited by 680
Self-citationWiegman, A., Hutten, B. A., de Groot, E., Rodenburg, J., Bakker, H. D., Büller, H. R., Sijbrands, E. J. G., & Kastelein, J. J. P. (2004) · JAMA · doi:10.1001/jama.292.3.331 · Cited by 649
Self-citationCerivastatin and Reports of Fatal Rhabdomyolysis
Staffa, J. A., Chang, J., & Green, L. (2002) · New England Journal of Medicine · doi:10.1056/nejm200202143460721 · Cited by 626
Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients
Goldberg, A. C., Hopkins, P. N., Toth, P. P., Ballantyne, C. M., Rader, D. J., Robinson, J. G., Daniels, S. R., Gidding, S. S., de Ferranti, S. D., Ito, M. K., et al. (2011) · Journal of clinical lipidology · doi:10.1016/j.jacl.2011.03.001 · Cited by 622
Talmud, P. J., Shah, S., Whittall, R., Futema, M., Howard, P., Cooper, J. A., Harrison, S. C., Li, K., Drenos, F., Karpe, F., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)62127-8 · Cited by 591
Self-citationFamilial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients
Goldberg, A. C., Hopkins, P. N., Toth, P. P., Ballantyne, C. M., Rader, D. J., Robinson, J. G., Daniels, S. R., Gidding, S. S., de Ferranti, S. D., Ito, M. K., et al. (2011) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2011.04.003 · Cited by 545
Hippisley-Cox, J., & Coupland, C. (2010) · BMJ · doi:10.1136/bmj.c2197 · Cited by 512
Narrative review: statin-related myopathy
Joy, T. R., & Hegele, R. A. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-12-200906160-00009 · Cited by 453
Sjouke, B., Kusters, D. M., Kindt, I., Besseling, J., Defesche, J. C., Sijbrands, E. J. G., Roeters van Lennep, J. E., Stalenhoef, A. F. H., Wiegman, A., de Graaf, J., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehu058 · Cited by 443
Self-citationPatients with elevated liver enzymes are not at higher risk for statin hepatotoxicity
Chalasani, N., Aljadhey, H., Kesterson, J., Murray, M. D., & Hall, S. D. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.02.015 · Cited by 441
McKenney, J. M., Davidson, M. H., Jacobson, T. A., & Guyton, J. R. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.02.030 · Cited by 431
McCrindle, B. W., Urbina, E. M., Dennison, B. A., Jacobson, M. S., Steinberger, J., Rocchini, A. P., Hayman, L. L., & Daniels, S. R. (2007) · Circulation · doi:10.1161/circulationaha.107.181946 · Cited by 418
Risk of incident diabetes among patients treated with statins: population based study
Carter, A. A., Gomes, T., Camacho, X., Juurlink, D. N., Shah, B. R., & Mamdani, M. M. (2013) · BMJ · doi:10.1136/bmj.f2610 · Cited by 404
Benn, M., Watts, G. F., Tybjærg-Hansen, A., & Nordestgaard, B. G. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw028 · Cited by 400
Association Between Familial Hypercholesterolemia and Prevalence of Type 2 Diabetes Mellitus
Besseling, J., Kastelein, J. J. P., Defesche, J. C., Hutten, B. A., & Hovingh, G. K. (2015) · JAMA · doi:10.1001/jama.2015.1206 · Cited by 387
Bradford, R. H. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.1991.00400010067008 · Cited by 372
Early statin therapy restores endothelial function in children with familial hypercholesterolemia
de Jongh, S., Lilien, M. R., op’t Roodt, J., Stroes, E. S. G., Bakker, H. D., & Kastelein, J. J. P. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02593-7 · Cited by 367
Child–Parent Familial Hypercholesterolemia Screening in Primary Care
Wald, D. S., Bestwick, J. P., Morris, J. K., Whyte, K., Jenkins, L., & Wald, N. J. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1602777 · Cited by 320
Tonstad, S., Joakimsen, O., Stensland-Bugge, E., Leren, T. P., Ose, L., Russell, D., & Bønaa, K. H. (1996) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.16.8.984 · Cited by 314
Self-citationMeta-Analysis of Impact of Different Types and Doses of Statins on New-Onset Diabetes Mellitus
Navarese, E. P., Buffon, A., Andreotti, F., Kozinski, M., Welton, N., Fabiszak, T., Caputo, S., Grzesk, G., Kubica, A., Swiatkiewicz, I., et al. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.12.037 · Cited by 308
de Jongh, S., Ose, L., Szamosi, T., Gagné, C., Lambert, M., Scott, R., Perron, P., Dobbelaere, D., Saborio, M., Tuohy, M. B., et al. (2002) · Circulation · doi:10.1161/01.cir.0000035247.42888.82 · Cited by 308
Pedersen, T. R. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.156.18.2085 · Cited by 286
Stein, E. A., Illingworth, D. R., Kwiterovich, Jr., Liacouras, C. A., Siimes, M. A., Jacobson, M. S., Brewster, T. G., Hopkins, P., Davidson, M., Graham, K., et al. (1999) · JAMA · doi:10.1001/jama.281.2.137 · Cited by 270
McCrindle, B. W., Ose, L., & Marais, A. D. (2003) · The Journal of Pediatrics · doi:10.1016/s0022-3476(03)00186-0 · Cited by 269
An Assessment of Statin Safety by Hepatologists
Cohen, D. E., Anania, F. A., & Chalasani, N. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.12.014 · Cited by 269
Humphries, S. E., Whittall, R. A., Hubbart, C. S., Maplebeck, S., Cooper, J. A., Soutar, A. K., Naoumova, R., Thompson, G. R., Seed, M., Durrington, P. N., et al. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2006.038356 · Cited by 267
Self-citationStatin Safety: An Overview and Assessment of the Data—2005
Bays, H. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.12.006 · Cited by 264
Development of coronary heart disease in familial hypercholesterolemia.
Mabuchi, H., Koizumi, J., Shimizu, M., & Takeda, R. (1989) · Circulation · doi:10.1161/01.cir.79.2.225 · Cited by 244
Avis, H. J., Vissers, M. N., Stein, E. A., Wijburg, F. A., Trip, M. D., Kastelein, J. J. P., & Hutten, B. A. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.145151 · Cited by 241
MYANT, N. (1993) · Atherosclerosis · doi:10.1016/0021-9150(93)90171-p · Cited by 229
Sinzinger, H., & O'Grady, J. (2004) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2003.02044.x · Cited by 223
Statins and Liver Toxicity: A Meta‐Analysis
de Denus, S., Spinler, S. A., Miller, K., & Peterson, A. M. (2004) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.24.6.584.34738 · Cited by 220
Futema, M., Shah, S., Cooper, J. A., Li, K., Whittall, R. A., Sharifi, M., Goldberg, O., Drogari, E., Mollaki, V., Wiegman, A., et al. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2014.231365 · Cited by 213
Self-citationUsifo, E., Leigh, S. E. A., Whittall, R. A., Lench, N., Taylor, A., Yeats, C., Orengo, C. A., Martin, A. C. R., Celli, J., & Humphries, S. E. (2012) · Annals of Human Genetics · doi:10.1111/j.1469-1809.2012.00724.x · Cited by 201
Self-citationKwiterovich, P. O., Fredrickson, D. S., & Levy, R. I. (1974) · Journal of Clinical Investigation · doi:10.1172/jci107670 · Cited by 191
Goldstein, J. L., Helgeson, J. A., & Brown, M. S. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)50610-4 · Cited by 181
Ten-Year Follow-up After Initiation of Statin Therapy in Children With Familial Hypercholesterolemia
Kusters, D. M., Avis, H. J., de Groot, E., Wijburg, F. A., Kastelein, J. J. P., Wiegman, A., & Hutten, B. A. (2014) · JAMA · doi:10.1001/jama.2014.8892 · Cited by 176
Self-citationShort-Term Efficacy and Safety of Pravastatin in 72 Children with Familial Hypercholesterolemia
Knipscheer, H. C., Boelen, C. C. A., Kastelein, J. J. P., Van Diermen, D. E., Groenemeijer, B. E., Van Den Ende, A., Büller, H. R., & Bakker, H. D. (1996) · Pediatric Research · doi:10.1203/00006450-199605000-00021 · Cited by 166
Starr, B., Hadfield, S. G., Hutten, B. A., Lansberg, P. J., Leren, T. P., Damgaard, D., Neil, H. A. W., & Humphries, S. E. (2008) · Clinical Chemistry and Laboratory Medicine · doi:10.1515/cclm.2008.135 · Cited by 165
Self-citationEfficacy and Safety of Rosuvastatin Therapy for Children With Familial Hypercholesterolemia
Avis, H. J., Hutten, B. A., Gagné, C., Langslet, G., McCrindle, B. W., Wiegman, A., Hsia, J., Kastelein, J. J. P., & Stein, E. A. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.10.042 · Cited by 165
Self-citationTreatment of Familial Hypercholesterolemia in Children and Adolescents: Effect of Lovastatin
Lambert, M. A., Lupien, P.-J., Gagné, C., Levy, E. H., Blaichman, S., Langlois, S., Hayden, M. R., Rose, V., Clarke, J. T. R., Wolfe, B. M. J., et al. (1996) · PEDIATRICS · doi:10.1542/peds.97.5.619 · Cited by 158
Descamps, O. S., Tenoutasse, S., Stéphenne, X., Gies, I., Beauloye, V., Lebrethon, M.-C., de Beaufort, C. E., Waele, K. D., Scheen, A. J., Rietzschel, E. R., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.06.016 · Cited by 153
Cenedella, R. J. (1996) · Survey of Ophthalmology · doi:10.1016/s0039-6257(96)82007-8 · Cited by 136
ClinVar database of global familial hypercholesterolemia‐associated DNA variants
Iacocca, M. A., Chora, J. R., Carrié, A., Freiberger, T., Leigh, S. E. A., Defesche, J. C., Kurtz, C. L., DiStefano, M. T., Santos, R. D., Humphries, S. E., et al. (2018) · Human Mutation · doi:10.1002/humu.23634 · Cited by 128
Self-citationTeramoto, T., Kobayashi, M., Tasaki, H., Yagyu, H., Higashikata, T., Takagi, Y., Uno, K., Baccara‐Dinet, M. T., & Nohara, A. (2016) · Circulation Journal · doi:10.1253/circj.cj-16-0387 · Cited by 127
Clauss, S. B., Holmes, K. W., Hopkins, P. N., Stein, E. A., Cho, M., Tate, A. C., Johnson‐Levonas, A. O., & Kwiterovich, P. O. (2005) · PEDIATRICS · doi:10.1542/peds.2004-2090 · Cited by 124
Kotze, M. J., de Villiers, W. J. S., Steyn, K., Kriek, J. A., Marais, A. D., Langenhoven, E., Herbert, J. S., van Roggen, J. F. G., van der Westhuyzen, D. R., & Coetzee, G. A. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.10.1460 · Cited by 118
Arambepola, C., Farmer, A. A., Perera, R., & Neil, H. A. W. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.09.030 · Cited by 112
Futema, M., Whittall, R., Kiley, A., Steel, L. K., Cooper, J. A., Badmus, E., Leigh, S. E. A., Karpe, F., Neil, H. A. W., & Humphries, S. E. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.04.011 · Cited by 106
Self-citationMolecular Basis of Autosomal Dominant Hypercholesterolemia
van der Graaf, A., Avis, H. J., Kusters, D. M., Vissers, M. N., Hutten, B. A., Defesche, J. C., Huijgen, R., Fouchier, S. W., Wijburg, F. A., Kastelein, J. J. P., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.979450 · Cited by 106
Self-citationAssociation of Statin Use With Cataracts
Leuschen, J., Mortensen, E. M., Frei, C. R., Mansi, E. A., Panday, V. A., & Mansi, I. A. (2013) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2013.4575 · Cited by 102
Couture, P., Brun, L., Szöts, F., Lelièvre, M., Gaudet, D., Després, J., Simard, J., Lupien, P. J., & Gagné, C. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.6.1007 · Cited by 102
Graham, C. A., McIlhatton, B. P., Kirk, C. W., Beattie, E. D., Lyttle, K., Hart, P., Neely, R. D. G., Young, I. S., & Nicholls, D. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.02.016 · Cited by 101
Umans-Eckenhausen, M. A. W., Sijbrands, E. J. G., Kastelein, J. J. P., & Defesche, J. C. (2002) · Circulation · doi:10.1161/01.cir.0000041253.61683.08 · Cited by 100
Vuorio, A. F., Docherty, K. F., Humphries, S. E., Kuoppala, J., & Kovanen, P. T. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.10.032 · Cited by 97
Self-citationSun, X.-M., Patel, D. D., Knight, B. L., & Soutar, A. K. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(97)00181-0 · Cited by 89
Statin‐Associated Peripheral Neuropathy: Review of the Literature
Chong, P. H., Boskovich, A., Stevkovic, N., & Bartt, R. E. (2004) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.24.13.1194.38084 · Cited by 89
The UCL low-density lipoprotein receptor gene variant database: pathogenicity update
Leigh, S., Futema, M., Whittall, R., Taylor-Beadling, A., Williams, M., den Dunnen, J. T., & Humphries, S. E. (2017) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2016-104054 · Cited by 88
Self-citationO’Connor, P. A., Feely, J., & Shepherd, J. (1990) · BMJ · doi:10.1136/bmj.300.6725.667 · Cited by 85
Koeijvoets, K. C. M. C., Rodenburg, J., Hutten, B. A., Wiegman, A., Kastelein, J. J. P., & Sijbrands, E. J. G. (2005) · Circulation · doi:10.1161/circulationaha.105.565507 · Cited by 84
Self-citationMcCrindle, B. W., Helden, E., Cullen-Dean, G., & Conner, W. T. (2002) · Pediatric Research · doi:10.1203/00006450-200206000-00009 · Cited by 78
Statins for children with familial hypercholesterolemia
Vuorio, A. F., Kuoppala, J., Kovanen, P. T., Humphries, S. E., Strandberg, T. E., Tonstad, S., & Gylling, H. K. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006401.pub2 · Cited by 77
Self-citationHumphries, S. E., Cranston, T., Allen, M., Middleton-Price, H. R., Fernandez, M. C., Senior, V., Hawe, E., Iversen, A., Wray, R., Crook, M. A., et al. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0019-z · Cited by 75
Self-citationStatins for children with familial hypercholesterolemia
Vuorio, A. F., Kuoppala, J., Kovanen, P. T., Humphries, S. E., Tonstad, S., Wiegman, A., & Drogari, E. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006401.pub3 · Cited by 68
Self-citationVlahos, A. P., Naka, K. Κ., Bechlioulis, A., Theoharis, P., Vakalis, K., Moutzouri, E., Miltiadous, G. A., Michalis, L. K., Siamopoulou‐Mavridou, A., Elisaf, M., et al. (2013) · Pediatric Cardiology · doi:10.1007/s00246-013-0742-0 · Cited by 65
Vohl, M., Szöts, F., Lelièvre, M., Lupien, P.-J., Bergeron, J., Gagné, C., & Couture, P. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00584-6 · Cited by 64
Harris, M. L., Bron, A. J., Brown, N., KEECH, A. C., Wallendszus, K., Armitage, J., MacMahon, S. W., Snibson, G. R., & Collins, R. (1995) · British Journal of Ophthalmology · doi:10.1136/bjo.79.11.996 · Cited by 63
An Assessment of Statin Safety by Neurologists
Brass, L. M., Alberts, M. J., & Sparks, L. D. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.12.017 · Cited by 62
Braamskamp, M. J. A. M., Langslet, G., McCrindle, B. W., Cassiman, D. M., Francis, G. A., Gagné, C., Gaudet, D., Morrison, K. M., Wiegman, A., Turner, T. A., et al. (2015) · Journal of clinical lipidology · doi:10.1016/j.jacl.2015.07.011 · Cited by 57
Self-citationVuorio, A. F., Aalto‐Setälä, K., Koivisto, U., Turtola, H., Nissen, H., Kovanen, P. T., Miettinen, T. A., Gylling, H. K., Oksanen, H. M., & KONTULA, K. K. (2001) · Annals of Medicine · doi:10.3109/07853890108995954 · Cited by 56
Self-citationCarreau, V., Girardet, J.-P., & Bruckert, É. (2011) · Pediatric Drugs · doi:10.2165/11591650-000000000-00000 · Cited by 54
Miltiadous, G. A., Xenophontos, S. L., Bairaktari, E. T., Ganotakis, M., Cariolou, M. A., & Elisaf, M. (2005) · Pharmacogenetics and Genomics · doi:10.1097/01213011-200504000-00005 · Cited by 54
Dirisamer, A., Hachemian, N., Bucek, R. A., Wolf, F., Reiter, M., & Widhalm, K. (2003) · European Journal of Pediatrics · doi:10.1007/s00431-003-1181-3 · Cited by 52
Association of HMG-CoA Reductase Inhibitors with Neuropathy
Backes, J. M., & Howard, P. A. (2003) · Annals of Pharmacotherapy · doi:10.1177/106002800303700220 · Cited by 52
Hedman, M., Matikainen, T., Föhr, A., Lappi, M., Piippo, S., Nuutinen, M., & Antikainen, M. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1541 · Cited by 47
Persistence with Statins and Incident Cataract: A Population-Based Historical Cohort Study
Chodick, G., Heymann, A. D., Flash, S., Kokia, E. S., & Shalev, V. (2010) · Annals of Epidemiology · doi:10.1016/j.annepidem.2009.10.007 · Cited by 46
Skoumas, J., Liontou, C., Chrysohoou, C. A., Masoura, C., Aznaouridis, K. A., Pitsavos, C., & Stefanadis, C. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.08.047 · Cited by 41
Langslet, G., Breazna, A., & Drogari, E. (2016) · Journal of clinical lipidology · doi:10.1016/j.jacl.2016.05.010 · Cited by 40
Self-citationRecent Statin Use and Cataract Surgery
Fong, D. S., & Poon, K. T. (2011) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2011.08.001 · Cited by 39
Pang, J., Lansberg, P. J., & Watts, G. F. (2016) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.34108 · Cited by 33
Screening for Hyperlipidaemia in Childhood
Wray, R., Neil, H., & Rees, J. (1996) · Journal of the Royal College of Physicians of London · doi:10.1016/s0035-8819(25)00435-0 · Cited by 29
Braamskamp, M. J. A. M., Kusters, D. M., Wiegman, A., Avis, H. J., Wijburg, F. A., Kastelein, J. J. P., van Trotsenburg, A. S. P., & Hutten, B. A. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.05.034 · Cited by 27
Self-citationGandelman, K., Glue, P., Laskey, R. E., Jones, J., LaBadie, R. R., & Ose, L. (2011) · Pediatric Cardiology · doi:10.1007/s00246-011-9885-z · Cited by 26
Chan, D. C., Pang, J., Barrett, P. H. R., SULLIVAN, D. R., Mori, T. A., Burnett, J. R., van BOCKXMEER, F. M., & Watts, G. F. (2016) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2016.07.012 · Cited by 25
Harada‐Shiba, M., Kastelein, J. J. P., Hovingh, G. K., Ray, K. K., Ohtake, A., Arisaka, O., Ohta, T., Okada, T., Suganami, H., & Wiegman, A. (2017) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.42242 · Cited by 25
Self-citationFamilial hypercholesterolemia in children and adolescents
McCrindle, B. W. (2012) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283587522 · Cited by 24
Hoffmann, U., Dirisamer, A., Heher, S., Kostner, K., Widhalm, K., & Neunteufl, T. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02393-7 · Cited by 23
Screening for familial hyper-beta-lipoproteinaemia in children in hospital.
Leonard, J. V., Fosbrooke, A. S., Lloyd, J. K., et al. (1976) · Archives of Disease in Childhood · doi:10.1136/adc.51.11.842 · Cited by 18
Dietary treatment for familial hypercholesterolaemia.
Poustie, V., & Rutherford, P. (2001) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001918 · Cited by 17
Statins and new‐onset diabetes mellitus – a risk lacking in familial hypercholesterolaemia
Vuorio, A. F., Strandberg, T. E., Schneider, W. J., & Kovanen, P. T. (2015) · Journal of Internal Medicine · doi:10.1111/joim.12405 · Cited by 13
Self-citationINTERIM Guidelines for the Diagnosis and Management of Familial Hypercholesterolaemia
SULLIVAN, D. R., Hamilton‐Craig, I. R., van Bockxmeer, F., & Watts, G. F. (2012) · Heart Lung and Circulation · doi:10.1016/j.hlc.2011.11.006 · Cited by 13
Tada, H., Kobayashi, J., Kawashiri, M., Miyashita, K., Nohara, A., Inazu, A., Nakajima, K., Mabuchi, H., & Yamagishi, M. (2016) · Lipids in Health and Disease · doi:10.1186/s12944-016-0238-z · Cited by 9
The importance of monitoring adverse events in statin, and other, clinical trials
Golomb, B. A. (2013) · Clinical Investigation · doi:10.4155/cli.13.81 · Cited by 6
Cited by
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz455 · Cited by 8,961
Grundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., Braun, L. T., de Ferranti, S., Faiella-Tommasino, J., Forman, D. E., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000625 · Cited by 6,185
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.08.014 · Cited by 4,854
Grundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., Braun, L. T., de Ferranti, S., Faiella-Tommasino, J., Forman, D. E., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.11.003 · Cited by 2,691
Wiegman, A., Gidding, S. S., Watts, G. F., Chapman, M. J., Ginsberg, H. N., Cuchel, M., Ose, L., Averna, M., Boileau, C., Borén, J., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv157 · Cited by 891
Self-citation
Metadata
- Authors
- Vuorio, A., Kuoppala, J., Kovanen, P. T., Humphries, S. E., Tonstad, S., Wiegman, A., Drogari, E., & Ramaswami, U.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2017-07-07
- Volume
- 2019
- Issue
- 11
- Pages
- CD006401-CD006401
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W1803918690
- Cited by
- 265
- References
- 104
- FWCI
- 20.72
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.